BioRestorative Therapies, Inc.
BRTXNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $1.29M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.16$8.56
- Volume (live)
- -
- Avg. volume (3M)
- 39.89K
BioRestorative Therapies (BRTX) Stock Price & Financial Analysis
BioRestorative Therapies Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.28 - $1.50 |
|---|---|
| 52-Week High | $8.56 |
| 52-Week Low | $0.16 |
| Open | $1.50 |
| Volume (last close) | 27.80K |
| Average Volume (3M) | 39.89K |
| Revenue (TTM) | 357.87K |
|---|---|
| Net Income (TTM) | -11.06M |
| Free Cash Flow (TTM) | -11.90M |
| EPS (TTM) | −$2.30 |
| Profit Margin | -3089.55% |
| Operating Margin | -3975.00% |
| Return on Equity (ROE) | -365.43% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.29M |
|---|---|
| Shares Outstanding | 886.39K |
| Price to Sales (P/S) | 3.62 |
| Price to Book (P/B) | 0.43 |
| EV/EBITDA | 0.14 |
| 50-Day MA | $3.17 |
|---|---|
| 200-Day MA | $2.39 |
| 1-Year Change | −7.59% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
BioRestorative Therapies at a Glance
As of the Oct 15, 2026 close, BioRestorative Therapies (BRTX) has a market capitalization of $1.29M. The stock trades at 3.6× sales. Over the trailing twelve months it lost $11.06M on revenue of $357.87K and burned $11.90M of free cash flow. Revenue fell 8.5% year over year.
As of its latest reported balance sheet, it holds $3.11M in cash and securities against $34.52K of debt, a net cash position of $3.08M.
BioRestorative Therapies does not currently pay a dividend.
The share price is down 7.6% over the past year. At $1.46 (the Oct 15, 2026 close) it sits within its 52-week range of $0.16 to $8.56, below its 200-day moving average of $2.39.
Frequently Asked Questions About BioRestorative Therapies
What is the current stock price for BRTX?
As of the Oct 15, 2026 close, BRTX stock trades at $1.46. The 52-week range is $0.16–$8.56, with a day range of $1.28–$1.50.
What is the P/E ratio for BRTX?
The P/E ratio (Price-to-Earnings) for BRTX is shown in the Key Statistics section. This valuation metric helps compare BioRestorative Therapies, Inc. to industry peers.
Does BRTX pay dividends?
BioRestorative Therapies does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BRTX?
Analyst ratings and recommendations for BRTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of BRTX?
As of the Oct 15, 2026 close, BioRestorative Therapies's market capitalization is $1.3M, classifying it as a micro-cap company. BioRestorative Therapies operates in the Healthcare sector within the Biotechnology industry.